ADM's Earnings Recovery Supports Its Valuation, but Bargains Are Scarcer

Archer-Daniels-Midland trades at roughly 15 times expected 2026 adjusted earnings, based on the guidance the company recently raised. An Insider Monkey analysis says that multiple looks defensible if the recovery continues, but the shares are no longer an obvious bargain.

Earnings drive the case

ADM lifted its 2026 adjusted earnings-per-share outlook to $5.15-$5.60, from $4.15-$4.70. At the roughly $80.45 share price cited in the article, the stock’s trailing price-to-earnings ratio was about 22, based on diluted earnings per share of about $3.66.

The company’s second-quarter results showed improvement across several segments. Operating profit at Ag Services & Oilseeds jumped 129% from a year earlier, while Carbohydrate Solutions rose 22% and Nutrition increased 51%.

Insider Monkey points to ADM’s network across agricultural sourcing, transport, processing, biofuels, food ingredients and nutrition as a reason the company may merit a premium. But it notes that earnings remain exposed to crop prices, energy costs, trade policies and biofuel markets.

A tighter valuation cushion

ADM’s roughly 15-times forward multiple is above several levels cited for 2021 through 2024, when the ratio ranged from 10.9 to 14.5. The analysis says the market has already priced in part of an earnings recovery, leaving less protection if results disappoint.

The article also compares ADM with peers. It says Ingredion and Bunge trade closer to 11 to 12 times forward earnings, while Darling Ingredients is around 13 to 17 times, depending on estimates. In Insider Monkey’s view, ADM’s scale and dividend record help explain its premium, but do not make the valuation a standout bargain.

Cash needs and next steps

ADM raised its quarterly dividend to $0.52 per share, marking 53 consecutive years of dividend growth, according to the article. It generated $1.30 billion in operating cash flow during the first half of 2026 and expects full-year capital spending of $1.3 billion to $1.5 billion.

Insider Monkey says the outlook depends on factors including biofuel economics, energy prices, processing margins and further improvement in Nutrition. If earnings keep recovering, the current multiple may prove reasonable; weaker results could make it harder to justify.